Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug Development.
Sano M, Cummings JL, Feldman HH, Hansson O, van der Flier WM, Bardtrum L, Jeppesen R, Johannsen P, Léon T, Hansen CT, Scheltens P. Sano M, et al. Among authors: leon t. Alzheimers Dement. 2024 Dec;20 Suppl 6:e088735. doi: 10.1002/alz.088735. Alzheimers Dement. 2024. PMID: 39782639
Drug Development.
van der Flier WM, Scheltens P, Feldman HH, Hansson O, Sano M, Bardtrum L, Johannsen P, Jeppesen R, Hansen CT, Leon T, Cummings JL. van der Flier WM, et al. Among authors: leon t. Alzheimers Dement. 2024 Dec;20 Suppl 6:e088793. doi: 10.1002/alz.088793. Alzheimers Dement. 2024. PMID: 39782588
Drug Development.
Feldman HH, Scheltens P, Hansson O, Sano M, van der Flier WM, Bardtrum L, Johannsen P, Jeppesen R, Leon T, Hansen CT, Cummings JL. Feldman HH, et al. Among authors: leon t. Alzheimers Dement. 2024 Dec;20 Suppl 6:e083684. doi: 10.1002/alz.083684. Alzheimers Dement. 2024. PMID: 39782504
Drug Development.
Leon T. Leon T. Alzheimers Dement. 2024 Dec;20 Suppl 6:e083429. doi: 10.1002/alz.083429. Alzheimers Dement. 2024. PMID: 39782494
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.
Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, León T, Scheltens P. Cummings JL, et al. Among authors: leon t. Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi: 10.1186/s13195-024-01666-7. Alzheimers Res Ther. 2025. PMID: 39780249 Clinical Trial.
Alzheimer's disease drug development in an evolving therapeutic landscape.
Weninger S, Irizarry MC, Fleisher AS, León T, Maruff P, Miller DS, Seleri S, Carrillo MC, Weber CJ. Weninger S, et al. Among authors: leon t. Alzheimers Dement (N Y). 2024 Nov 30;10(4):e70015. doi: 10.1002/trc2.70015. eCollection 2024 Oct-Dec. Alzheimers Dement (N Y). 2024. PMID: 39748838 Free PMC article.
220 results